Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug;28(8):3151-3159.
doi: 10.1007/s00330-017-5213-1. Epub 2018 Jan 2.

18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients

Kirsten M Selnæs  1   2 , Brage Krüger-Stokke  3   4 , Mattijs Elschot  3 , Frode Willoch  5 , Øystein Størkersen  6 , Elise Sandsmark  3 , Siver A Moestue  3 , May-Britt Tessem  3 , Dag Halvorsen  7 , Eirik Kjøbli  7 , Anders Angelsen  8 , Sverre Langørgen  4 , Helena Bertilsson  7   9 , Tone F Bathen  3
Affiliations

18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients

Kirsten M Selnæs et al. Eur Radiol. 2018 Aug.

Abstract

Objective: To investigate the diagnostic potential of simultaneous 18F-fluciclovine PET/MRI for pelvic lymph node (LN) staging in patients with high-risk prostate cancer.

Methods: High-risk prostate cancer patients (n=28) underwent simultaneous 18F-fluciclovine PET/MRI prior to surgery. LNs were removed according to a predefined template of eight regions. PET and MR images were evaluated for presence of LN metastases according to these regions. Sensitivity/specificity for detection of LN metastases were calculated on patient and region basis. Sizes of LN metastases in regions with positive and negative imaging findings were compared with linear mixed models. Clinical parameters of PET-positive and -negative stage N1 patients were compared with the Mann-Whitney U test.

Results: Patient- and region-based sensitivity/specificity for detection of pelvic LN metastases was 40 %/87.5 % and 35 %/95.7 %, respectively, for MRI and 40 %/100 % and 30 %/100 %, respectively, for PET. LN metastases in true-positive regions were significantly larger than metastases in false-negative regions. PET-positive stage N1 patients had higher metastatic burden than PET-negative N1 patients.

Conclusion: Simultaneous 18F-fluciclovine PET/MRI provides high specificity but low sensitivity for detection of LN metastases in high-risk prostate cancer patients. 18F-Fluciclovine PET/MRI scan positive for LN metastases indicates higher metastatic burden than negative scan.

Key points: • 18F-Fluciclovine PET/MRI has high specificity for detection of lymph node metastasis. • 18F-Fluciclovine PET/MRI lacks sensitivity to replace ePLND. • 18F-Fluciclovine PET/MRI may be used to aid surgery and select adjuvant therapy. • 18F-Fluciclovine PET-positive patients have more extensive disease than PET-negative patients. • Size of metastatic lymph nodes is an important factor for detection.

Keywords: Adenocarcinoma; FACBC; Magnetic resonance imaging; N-staging; Positron-emission tomography.

PubMed Disclaimer

Comment in

References

    1. Radiology. 2014 Mar;270(3):849-56 - PubMed
    1. Jpn J Clin Oncol. 2016 Feb;46(2):152-62 - PubMed
    1. J Nucl Med. 2007 Jan;48(1):56-63 - PubMed
    1. Eur Urol. 2014 Aug;66(2):191-9 - PubMed
    1. Radiology. 2010 Mar;254(3):925-33 - PubMed

Publication types

MeSH terms

LinkOut - more resources